Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

'Renal-dose' fenoldopam for early-stage renal dysfunction in critically ill patients

Nature Clinical Practice Nephrology volume 2, pages 548–549 (2006)Cite this article

boxed-textBrienza N et al. (2006) A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34: 707–714

Fenoldopam is not yet licensed for use as a nephroprotective agent in routine practice, but some potential benefit in the prevention of renal injury is evident and should be verified in a phase III study

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Metnitz PG et al. (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30: 2051–2058

    Article  Google Scholar 

  2. Jones D and Bellomo R (2005) Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition? J Intensive Care Med 20: 199–211

    Article  Google Scholar 

  3. Tumlin JA et al. (2005) Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46: 26–34

    Article  CAS  Google Scholar 

  4. Morelli A et al. (2005) Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33: 2451–2456

    Article  CAS  Google Scholar 

  5. Bellomo R et al. (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204–R212

    Article  Google Scholar 

  6. Kellum JA (2005) Prophylactic fenoldopam for renal protection? No, thank you, not for me—not yet at least. Crit Care Med 33: 2681–2683

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. staff anesthesiologist in the Department of Pediatric Cardiology and Cardiac Surgery at the Bambino Gesù Hospital, Rome

    Zaccaria Ricci & Claudio Ronco

  2. Head of the Department of Nephrology, Dialysis and Transplantation, at S Bortolo Hospital, Vicenza, Italy

    Zaccaria Ricci & Claudio Ronco

Authors
  1. Zaccaria Ricci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio Ronco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zaccaria Ricci.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ricci, Z., Ronco, C. 'Renal-dose' fenoldopam for early-stage renal dysfunction in critically ill patients. Nat Rev Nephrol 2, 548–549 (2006). https://doi.org/10.1038/ncpneph0284

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0284

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing